White House, BIO Differ On Human Cloning Ban In House Testimony
Executive Summary
The Bush Administration favors the more restrictive of two House bills to ban human cloning.
You may also be interested in...
FDA Cloning Oversight Is "Tenuous," May Need Augmentation - Rep. Tauzin
FDA's regulatory authority over reproductive human cloning appears inadequate and should be either bolstered or granted to another federal agency, House Energy & Commerce Committee Chairman Tauzin (R-La.) told a Commerce/Oversight & Investigations Subcommittee hearing on human cloning March 28.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials